These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
69 related articles for article (PubMed ID: 17143302)
1. Use of physiological doses of human growth hormone in haematological patients receiving intensive chemotherapy promotes haematopoietic recovery: a double-blind randomized, placebo-controlled study. Sirohi B; Powles R; Morgan G; Treleaven J; Kulkarni S; Horton C; Saso R; Rolfe D; Cook G; Shaw C; Wass J Bone Marrow Transplant; 2007 Jan; 39(2):115-20. PubMed ID: 17143302 [TBL] [Abstract][Full Text] [Related]
2. Safety and efficacy of growth hormone (GH) during extended treatment of adult Japanese patients with GH deficiency (GHD). Chihara K; Kato Y; Kohno H; Takano K; Tanaka T; Teramoto A; Shimatsu A Growth Horm IGF Res; 2008 Aug; 18(4):307-17. PubMed ID: 18282776 [TBL] [Abstract][Full Text] [Related]
3. Prior and concurrent administration of recombinant human megakaryocyte growth and development factor in patients receiving consolidation chemotherapy for de novo acute myeloid leukemia--a randomized, placebo-controlled, double-blind safety and efficacy study. Geissler K; Yin JA; Ganser A; Sanz MA; Szer J; Raghavachar A; Hoelzer D; Martinez C; Taylor K; Kanz L; To LB; Archimbaud E Ann Hematol; 2003 Nov; 82(11):677-83. PubMed ID: 14530872 [TBL] [Abstract][Full Text] [Related]
4. Efficacy and safety of the dipeptidyl peptidase-4 inhibitor sitagliptin added to ongoing pioglitazone therapy in patients with type 2 diabetes: a 24-week, multicenter, randomized, double-blind, placebo-controlled, parallel-group study. Rosenstock J; Brazg R; Andryuk PJ; Lu K; Stein P; Clin Ther; 2006 Oct; 28(10):1556-68. PubMed ID: 17157112 [TBL] [Abstract][Full Text] [Related]
5. A multicenter, randomized, double-blind, placebo-controlled trial to evaluate the metabolic and respiratory effects of growth hormone in children with cystic fibrosis. Schnabel D; Grasemann C; Staab D; Wollmann H; Ratjen F; Pediatrics; 2007 Jun; 119(6):e1230-8. PubMed ID: 17545356 [TBL] [Abstract][Full Text] [Related]
6. Growth hormone treatment during hemodialysis in a randomized trial improves nutrition, quality of life, and cardiovascular risk. Feldt-Rasmussen B; Lange M; Sulowicz W; Gafter U; Lai KN; Wiedemann J; Christiansen JS; El Nahas M; J Am Soc Nephrol; 2007 Jul; 18(7):2161-71. PubMed ID: 17554147 [TBL] [Abstract][Full Text] [Related]
7. Safety and tolerability of growth hormone therapy in multiple system atrophy: a double-blind, placebo-controlled study. Holmberg B; Johansson JO; Poewe W; Wenning G; Quinn NP; Mathias C; Tolosa E; Cardozo A; Dizdar N; Rascol O; Slaoui T; ; Mov Disord; 2007 Jun; 22(8):1138-44. PubMed ID: 17469198 [TBL] [Abstract][Full Text] [Related]
8. Results of a phase III, randomized, placebo-controlled study of sorafenib in combination with carboplatin and paclitaxel as second-line treatment in patients with unresectable stage III or stage IV melanoma. Hauschild A; Agarwala SS; Trefzer U; Hogg D; Robert C; Hersey P; Eggermont A; Grabbe S; Gonzalez R; Gille J; Peschel C; Schadendorf D; Garbe C; O'Day S; Daud A; White JM; Xia C; Patel K; Kirkwood JM; Keilholz U J Clin Oncol; 2009 Jun; 27(17):2823-30. PubMed ID: 19349552 [TBL] [Abstract][Full Text] [Related]
9. Efficacy and tolerability of intranasal fentanyl spray 50 to 200 microg for breakthrough pain in patients with cancer: a phase III, multinational, randomized, double-blind, placebo-controlled, crossover trial with a 10-month, open-label extension treatment period. Kress HG; Orońska A; Kaczmarek Z; Kaasa S; Colberg T; Nolte T Clin Ther; 2009 Jun; 31(6):1177-91. PubMed ID: 19695386 [TBL] [Abstract][Full Text] [Related]
10. Botulinum toxin type a prophylactic treatment of episodic migraine: a randomized, double-blind, placebo-controlled exploratory study. Aurora SK; Gawel M; Brandes JL; Pokta S; Vandenburgh AM; Headache; 2007 Apr; 47(4):486-99. PubMed ID: 17445098 [TBL] [Abstract][Full Text] [Related]
11. Fentanyl buccal tablet for the relief of breakthrough pain in opioid-tolerant adult patients with chronic neuropathic pain: a multicenter, randomized, double-blind, placebo-controlled study. Simpson DM; Messina J; Xie F; Hale M Clin Ther; 2007 Apr; 29(4):588-601. PubMed ID: 17617282 [TBL] [Abstract][Full Text] [Related]
12. Safety and efficacy of the specific endothelin-A receptor antagonist ZD4054 in patients with hormone-resistant prostate cancer and bone metastases who were pain free or mildly symptomatic: a double-blind, placebo-controlled, randomised, phase 2 trial. James ND; Caty A; Borre M; Zonnenberg BA; Beuzeboc P; Morris T; Phung D; Dawson NA Eur Urol; 2009 May; 55(5):1112-23. PubMed ID: 19042080 [TBL] [Abstract][Full Text] [Related]
13. Analysis of stroke in ATHENA: a placebo-controlled, double-blind, parallel-arm trial to assess the efficacy of dronedarone 400 mg BID for the prevention of cardiovascular hospitalization or death from any cause in patients with atrial fibrillation/atrial flutter. Connolly SJ; Crijns HJ; Torp-Pedersen C; van Eickels M; Gaudin C; Page RL; Hohnloser SH; Circulation; 2009 Sep; 120(13):1174-80. PubMed ID: 19752319 [TBL] [Abstract][Full Text] [Related]
14. Efficacy of a pelargonium sidoides preparation in patients with the common cold: a randomized, double blind, placebo-controlled clinical trial. Lizogub VG; Riley DS; Heger M Explore (NY); 2007; 3(6):573-84. PubMed ID: 18005909 [TBL] [Abstract][Full Text] [Related]
15. Continuation and long-term maintenance treatment with Hypericum extract WS 5570 after recovery from an acute episode of moderate depression--a double-blind, randomized, placebo controlled long-term trial. Kasper S; Volz HP; Möller HJ; Dienel A; Kieser M Eur Neuropsychopharmacol; 2008 Nov; 18(11):803-13. PubMed ID: 18694635 [TBL] [Abstract][Full Text] [Related]
16. Duloxetine versus escitalopram and placebo: an 8-month, double-blind trial in patients with major depressive disorder. Pigott TA; Prakash A; Arnold LM; Aaronson ST; Mallinckrodt CH; Wohlreich MM Curr Med Res Opin; 2007 Jun; 23(6):1303-18. PubMed ID: 17559729 [TBL] [Abstract][Full Text] [Related]
17. Buprenorphine transdermal delivery system in adults with persistent noncancer-related pain syndromes who require opioid therapy: a multicenter, 5-week run-in and randomized, double-blind maintenance-of-analgesia study. Landau CJ; Carr WD; Razzetti AJ; Sessler NE; Munera C; Ripa SR Clin Ther; 2007 Oct; 29(10):2179-93. PubMed ID: 18042474 [TBL] [Abstract][Full Text] [Related]
18. A double-blind trial on prophylactic voriconazole (VRC) or placebo during induction chemotherapy for acute myelogenous leukaemia (AML). Vehreschild JJ; Böhme A; Buchheidt D; Arenz D; Harnischmacher U; Heussel CP; Ullmann AJ; Mousset S; Hummel M; Frommolt P; Wassmer G; Drzisga I; Cornely OA J Infect; 2007 Nov; 55(5):445-9. PubMed ID: 17822770 [TBL] [Abstract][Full Text] [Related]
19. Perioperative treatment with human growth hormone down-regulates apoptosis and increases superoxide production in PMN from patients undergoing infrarenal abdominal aortic aneurysm repair. Decker D; Springer W; Tolba R; Lauschke H; Hirner A; von Ruecker A Growth Horm IGF Res; 2005 Jun; 15(3):193-9. PubMed ID: 15935981 [TBL] [Abstract][Full Text] [Related]
20. Intravenous nitroglycerin for prevention of pancreatitis after therapeutic endoscopic retrograde cholangiography: a randomized, double-blind, placebo-controlled multicenter trial. Beauchant M; Ingrand P; Favriel JM; Dupuychaffray JP; Capony P; Moindrot H; Barthet M; Escourrou J; Plane C; Barrioz T; Lacoste L; Ingrand I Endoscopy; 2008 Aug; 40(8):631-6. PubMed ID: 18680075 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]